• Agentic AI transition: Fractal is shifting from traditional predictive analytics toward autonomous agentic AI layers that can plan, execute, and learn from feedback to solve core business problems.
• Macro demand dynamics: Although geopolitical uncertainty and trade headwinds have slowed client decision-making in certain sectors, strong enterprise appetite to adopt performance-enhancing AI continues to expand the overall market.
• Associate venture losses: Company profitability has been pressured by pre-breakeven Fractal Alpha units and a 31% stake in Cure.ai following US AID program cuts, though Cure.ai's loss impact is expected to decline in the next fiscal year.
• R&D investment intensity: R&D spending currently stands at 5% to 7% of overall revenue and is expected to sustain or increase, funding proprietary platforms like PiEvolve to automate data science workflows and improve profitability.